Wir sind mit live! Mehr erfahren

Cardinal Health

CAH

Börsenwert 58,8 Mrd. $

254,06 USD

+0,35

0,14 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

253,10

-0,96

0,38 %

1 Tag

0,14 %

5 Tage

6,33 %

1 Monat

9,25 %

3 Monate

11,08 %

6 Monate

19,22 %

Seit Jahresbeginn

23,5 %

1 Jahr

65,76 %

5 Jahre

433,4 %

10 Jahre

238,93 %

Profil: Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Mitarbeiter: 63.900

Gesundheitswesen Medizinischer Großhandel

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 57,8 %

Neutral 36,1 %

Negativ 6 %

Zacks Investment Research

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Zacks Investment Research

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge

As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge

Zacks Investment Research

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

Zacks Investment Research

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Zacks Investment Research

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Cardinal Health (CAH) Stock?

Zacks Investment Research

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

Zacks Investment Research

Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know

Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.

Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know

Zacks Investment Research

5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.

5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services. "We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.

Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt